Appointment expands business and political network and furthers the commercializing medical device technologies specific to needle-free injections as well as research and development of next-generation injectables across Latin America.

Approval Expands Inolife's Global Reach and Mission to Inject Well-Being Through Innovation

World-Renowned Diabetic Researcher Dr. Camillo Ricordi Joins Advisory Board

Inolife and Empower Clinics confirming a distribution agreement

Inolife partners with the University of Ottawa/CHEO-RI to work on genetically-engineered viruses to treat cancers

Inolife names Dr. Claude Vezeau as Chief Clinical Officer and Dr. Nadeem Siddiqui as Chief Scientific Officer, adding combined five decades of medical industry and research experience to Inolife's executive leadership.

Inolife takes further steps to meet the needs of the medical community through extended partnership, training, and systematization

Inolife is entering into a Definitive Agreement With ADW Diabetes to Serve Diabetics in USA with FDA Approved Needle-Free Insulin Injectors.